Cargando…
Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment
BACKGROUND: Nasopharyngeal carcinoma (NPC) is one of the most prevalent cancers with a poor prognosis. Immunotherapy, especially immune checkpoint blockade (ICB), is becoming a potential therapeutic choice for NPC patients. Thus, the identification of patients who could benefit from immunotherapy is...
Autores principales: | Sun, Yanbo, Liu, Yun, Chu, Hanqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234372/ https://www.ncbi.nlm.nih.gov/pubmed/37274867 http://dx.doi.org/10.1155/2023/2242577 |
Ejemplares similares
-
CircSOX9 acts as a molecular sponge of miR-485-3p to promote the progression of nasopharyngeal carcinoma
por: Sun, Yanbo, et al.
Publicado: (2022) -
Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment
por: Jiang, Jianyun, et al.
Publicado: (2022) -
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
por: Chen, Yu-Pei, et al.
Publicado: (2021) -
New insights into the tumour immune microenvironment of nasopharyngeal carcinoma
por: Forder, Aisling, et al.
Publicado: (2022) -
Update on Radiotherapy Changes of Nasopharyngeal Carcinoma Tumor Microenvironment
por: Zhu, Dao Qi, et al.
Publicado: (2023)